ChAracterizing the Remission Status in Patients With Ulcerative Colitis Treated by 5-ASA

NCT05992142 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Ulcerative Colitis

Interventions

DRUG: 5-ASA

Sponsor

Belgian Inflammatory Bowel Disease Research and Development (BIRD) VZW

Collaborators

[object Object]